AMA Update for Aug. 31, 2023: The latest FDA naloxone approvals and Overdose Awareness Day with Bobby Mukkamala, MD
·
13 Min Read

The latest FDA naloxone approvals and Overdose Awareness Day with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the current state of the overdose epidemic.

series
Behavioral Health
AMA Update
·
13 Min Read

The latest FDA naloxone approvals and Overdose Awareness Day with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the current state of the overdose epidemic.

series
Behavioral Health
AMA Update Podcast
·
8 Min Read

DEA opioid training requirements and the MATE Act explained with Sanjay Desai, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about DEA opioid training requirements.

series
Behavioral Health
AMA Update Podcast
AMA Update for Aug. 24, 2023: DEA opioid training requirements and the MATE Act explained with Sanjay Desai, MD
·
8 Min Read

DEA opioid training requirements and the MATE Act explained with Sanjay Desai, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about DEA opioid training requirements.

series
Behavioral Health
AMA Update
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of June 26, 2023

In the news: Eli Lilly’s experimental weight loss drug, updated physical activity guidelines for older adults, fentanyl laced with xylazine and more.

Publications & Newsletters
2023 Annual Meeting delegates from Kansas and Missouri
·
4 Min Read

Put naloxone in schools so it can save lives

Opioid overdose-reversing drugs such as naloxone save lives. They should be available in educational settings and public areas, the AMA says.

Behavioral Health
·
4 Min Read

AMA adopts new policies on substance use during second day of Annual Meeting

Policies address opioid crisis and medicinal use of psychedelics.

Press Releases
AMA in Action: Ending the overdose epidemic
UPDATED
·
4 Min Read

Advocacy in action: Ending the overdose epidemic

Science, evidence and compassion must guide patient care and policy change to end the drug-overdose epidemic.

Behavioral Health
Narcan nasal spray
·
4 Min Read

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 

Behavioral Health